FDA product approval
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Research compound · compound · checked 2026-10-09
Pinealon
Pinealon is listed here as a compound. Glu-Asp-Arg tripeptide examined in cellular oxidative-stress models. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use Pinealon or how much to take.
Last checked Oct 9, 2026 by PepBear. Not medical advice.
- FDA product
- not established
- Compounding
- not established
- Research
- investigational
- Sport
- unknown
What is Pinealon?
Other names in the library: EDR peptide, Pinealon (10MG). Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: 10 mg. A seller title is a listing. It does not prove the vial matches a paper.
Glu-Asp-Arg tripeptide examined in cellular oxidative-stress models.
Regulatory status, dated 2026-10-09
Compounding
not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.
Research
investigational. Cultured cerebellar granule cells, neutrophils and PC12 cells.
Sport
unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.
What the cited papers actually measured
We mark the cited papers as C for Cellular studies and small human reports involving Pinealon and Vesugen. and Reported metabolic and CNS observations; no established healthy-person longevity indication.. Small, incompletely described human reports plus preclinical research; mixed treatments and surrogate endpoints limit causal inference. The experimental peptide affected reactive oxygen species and cell survival in these models. Cell viability is not evidence of improved memory, neuroprotection or longevity in patients. Authors reported metabolic and CNS changes, alongside a pro-oxidant signal and reduced CD34-positive hematopoietic markers. Mixed preparations, unclear allocation/blinding and abstract participant-count inconsistencies. Biological-age surrogates do not establish lifespan benefit or safety. Risks on the record: Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
We mark the cited papers as C. That is our label for how strong those papers are. It does not say the compound works.
preclinical
The experimental peptide affected reactive oxygen species and cell survival in these models.
Cultured cerebellar granule cells, neutrophils and PC12 cells. Cell viability is not evidence of improved memory, neuroprotection or longevity in patients.
human-observation
Authors reported metabolic and CNS changes, alongside a pro-oxidant signal and reduced CD34-positive hematopoietic markers.
Report states 32 adults aged 41–83 with polymorbidity and organic brain syndrome in remission; Pinealon and Vesugen were studied. Mixed preparations, unclear allocation/blinding and abstract participant-count inconsistencies. Biological-age surrogates do not establish lifespan benefit or safety.
How long it lasts, how you store it, listed sizes
The catalog does not record a single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.
Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.
U-100 math for listed Pinealon sizes. Each cell is micrograms per syringe mark if you add that much liquid. The table does the same math as the calculator. It does not pick an amount for you.
| Listed vial | 1 mL liquid | 2 mL liquid | 3 mL liquid |
|---|---|---|---|
| 10 mg | 100 | 50 | 33.3 |
Risks and mix-ups already on the record
- Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
- No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
- No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.
People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.
Sources
- Pinealon primary study · PMID 21978084 · checked 2026-10-09
- Pinealon/Vesugen: small clinical observation report (2015) · checked 2026-10-09
Questions people ask
Is Pinealon FDA-approved?
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Does PepBear pick an amount of Pinealon?
The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.
Related cards
Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.